From the American Academy of Ophthalmology:
Written By: Beatrice Shelton
Feb. 05, 2019
If you were hoping that CBD, or cannabidiol, would offer a natural glaucoma remedy, the latest research is a downer. A new study suggests that CBD doesn’t lower eye pressure, it raises it. That’s bad because high eye pressure is the primary risk factor for glaucoma, one of the leading causes of blindness in the United States.
Glaucoma is a condition that damages the optic nerve at the back of the eye. It’s the nerve that transmits visual information to the brain, allowing us to see. Glaucoma is often linked to a buildup of pressure inside the eye. The increased pressure can damage the nerve, leading to permanent vision loss.
For their study, researchers from Indiana tested an eyedrop in rats that contained CBD, a component of cannabis that does not get you stoned. They found that it raised pressure inside the eyes by 18 percent for at least four hours after the drops were instilled.
The doctors at Kansas City Eye Clinic warn that if you are diagnosed with Glaucoma or have a family history of Glaucoma, that you get an eye exam and have your eye pressure checked and monitored if you are using CBD oil, topically or ingesting it. You can request an appointment here: request appointment.
The first and only FDA approved Trifocal IOL for cataract surgery is now available at KC Eye Clinic!
From Business Wire:
- PanOptix delivers an exceptional combination of near, intermediate and distance vision and substantially reduces the need for glasses1,2
- More than ninety-nine percent of PanOptix patients in the FDA clinical study said they would choose the same lens again1
PanOptix is clinically shown to deliver an exceptional combination of near, intermediate and distance vision while significantly reducing the need for glasses after surgery.1,2
PanOptix is already one of the leading presbyopia-correcting IOLs in more than 70 countries. It is designed for today’s active lifestyles, from viewing mobile devices and computer screens to high-quality distance vision in a range of lighting conditions. The new lens uses ENLIGHTEN® Optical Technology, a proprietary design that optimizes intermediate vision without compromising near and distance vision. Available in spherical and toric designs, PanOptix is built on Alcon’s proven AcrySof IQ IOL platform that has been implanted in more than 120 million eyes globally.
“We are proud to bring this new class of IOLs to the largest eye care market in the world,” said David J. Endicott, Chief Executive Officer of Alcon. “We are leveraging Alcon’s years of experience with PanOptix in other countries to provide the best possible training and support for U.S. surgeons. Our goal is to ensure optimal outcomes for cataract patients looking to correct their vision at all distances, with the vast majority of them never needing to wear glasses post-surgery.”
The FDA approval of PanOptix was based on a pivotal study at 12 investigational sites in the U.S. With this single trifocal lens design, PanOptix patients demonstrated exceptional, uninterrupted vision. The results also showed high patient satisfaction with more than ninety-nine percent of PanOptix patients saying they would choose the same lens again.1
More than 4 million cataract surgeries are performed each year in the U.S., which is projected to increase by more than 16 percent by the end of 2024.3,4 The presbyopia-correcting IOL market is expected to grow 60 percent by the end of 2024.4
“The U.S. ophthalmology community has been eagerly awaiting FDA approval of PanOptix. While participating in the clinical trial, I saw first-hand the impact of this lens on my patients,” said Kerry Solomon, M.D., Carolina Eyecare Physicians, PanOptix clinical trial investigator. “We know patients undergoing cataract surgery today want a replacement lens that delivers the vision they need to live full, active lives without always being dependent on glasses. PanOptix is an excellent lens option to address these needs and is clinically proven to deliver an outstanding range of vision.”
Attention: We will be closing early on Thursday September 26, 2019 for a private event. Appointments will end early this date. We request any Optical or Contact lens matters be taken care of before 3pm this date. We apologize for the inconvenience. Normal business hours will resume Friday at 8am.
Doctors and Staff of KC Eye Clinic
Deadly Falls in Older Americans Are Rising. Here’s How to Prevent Them by Katie Hafner – June 4, 2019
In the article above from the New York Times, adults over the age of 75 are at a higher risk of death from a fall than they were almost 20 years ago. Key tips: Exercise!, Mind Your Meds, Re-Accessorize, Eliminate Tripping Hazards, and Hydrate and go Early and Often to the Bathroom. Eyesight is a critical factor – avoid bifocals or progressive lenses when walking outside and keep a light on at night for visual access to the bathroom. Read the article to find out more key details for preventing a fall.
We will be closed the following business days to give our employees time with their families.
As always, we have a doctor on call for emergencies. If you need a prescription refill, please call your pharmacy. If you have a true medical emergency, please go to the ER.
Wednesday June 27th is National Sunglasses Day!
Sunglasses keep your eyes healthy by protecting them from harmful UV rays. To prevent UV-related eye damage, sunglasses should become part of each day’s “out-the-door” routine. UV damage is cumulative, occurring over a lifetime of exposure. Children are extra vulnerable, so get them in the habit of wearing sunglasses early! This will help to mitigate serious vision problems in the future.
Mark your calendar and stay tuned for specials in our Optical Shop!